Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Acta Pharmacol Sin ; 43(3): 520-528, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-34040166

RESUMEN

High mobility group box 1 (HMGB1) is a ubiquitous nuclear protein that is present in almost all cells and regulates the activity of innate immune responses in both intracellular and extracellular settings. Current evidence suggests that HMGB1 plays a pivotal role in human pathological and pathophysiological processes such as the inflammatory response, immune reactions, cell migration, aging, and cell death. Sepsis is a systemic inflammatory response syndrome (SIRS) that occurs in hosts in response to microbial infections with a proven or suspected infectious etiology and is the leading cause of death in intensive care units worldwide, particularly in the aging population. Dysregulated systemic inflammation is a classic characteristic of sepsis, and suppression of HMGB1 may ameliorate inflammation and improve patient outcomes. Here, we focus on the latest breakthroughs regarding the roles of HMGB1 in sepsis and sepsis-related organ injury, the ways by which HMGB1 are released, and the signaling pathways and therapeutics associated with HMGB1. This review highlights recent advances related to HMGB1: the regulation of HMBG1 might be helpful for both basic research and drug development for the treatment of sepsis and sepsis-related organ injury.


Asunto(s)
Proteína HMGB1/metabolismo , Insuficiencia Multiorgánica/patología , Sepsis/patología , Autofagia/fisiología , Trastornos de la Coagulación Sanguínea/patología , Síndrome de Liberación de Citoquinas/patología , Estrés del Retículo Endoplásmico/fisiología , Humanos , Inflamación/patología , Mediadores de Inflamación/metabolismo , Mitocondrias/patología , Insuficiencia Multiorgánica/tratamiento farmacológico , Receptor para Productos Finales de Glicación Avanzada/metabolismo , Sepsis/tratamiento farmacológico , Transducción de Señal/fisiología , Receptores Toll-Like/metabolismo
2.
Regen Ther ; 25: 395-404, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38435088

RESUMEN

Over the past decades, there has been ongoing effort to develop complex biomimetic tissue engineering strategies for in vitro cultivation and maintenance of organoids. The defined hydrogels can create organoid models for various organs by changing their properties and various active molecules. An increasing number of researches has been done on the application of hydrogels in organoids, and a large number of articles have been published on the topic. Although there have been existing reviews describing the application of hydrogels in the field of organoids, there is still a lack of comprehensive studies summarizing and analyzing the overall research trends in this field. The citation can be used as an indicator of the scientific influence of an article in its field. This study aims to evaluate the application of hydrogels in organoids through bibliometric analysis, and to predict the hotspots and developing trends in this field.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA